Delaware Health Alert Network #212
December 11, 2009 10:55am
Health
Advisory
ANTIVIRAL RECOMMENDATIONS
Delaware’s Division of Public Health (DPH) was notified Dec. 4 that routine testing by the Centers for Disease Control and
Prevention (CDC) identified oseltamivir (Tamiflu) resistant H1N1 influenza in a laboratory sample taken from a 52-year-old Kent County
resident. This is the only known oseltamivir resistant influenza infection known to date in a Delaware resident.
CDC has tested a total of 1,540 specimens submitted nationally, of which 15 were found resistant to oseltamivir. Because oseltamivir
resistence is infrequent, DPH is not proposing changes to previous antiviral recommendations (http://dhss.delaware.gov/dph/php/alerts/dhan201.html).
However, DPH is recommending that clinicians consider treatment with zanamivir (Relenza) if patients are not responsive to oseltamivir.
In addition, Peramivir should be considered for hospitalized patients who are seriously ill or who are not responding to either
oseltamivir or zanamivir (http://dhss.delaware.gov/dph/php/alerts/dhan206.html).
Questions about this health alert should be directed to DPH’s Immunization Program at 1-800-282-8672.
************************************
You are receiving this email because you are a registered member of the Delaware Health Alert Network. If you are not a member and would
like to subscribe, please register at https://www.healthalertde.org/.
Categories of Health Alert messages:
- Health Alert: Conveys the highest level of importance; warrants immediate action or attention.
- Health Advisory: Provides important information for a specific incident or situation; may not require immediate action.
- Health Update: Provides updated information regarding an incident or situation; unlikely to require immediate action.
